Pressemitteilungen zu "INCO Terms"

Umsatz beträgt 490 Millionen US-Dollar - Nicht-GAAP Umsatzrendite von 22%; GAAP Umsatzrendite von 5% - Nicht-GAAP verwässerter Gewinn je Aktie von 0,24 Dollar; GAAP verwässerter Gewinn je Aktie v

VMware Reports Third Quarter 2009 Results - Revenue of $490 Million - Non-GAAP Operating Margin of 22%; GAAP Operating Margin of 5% - Non-GAAP Diluted EPS of $0.24; GAAP Diluted EPS of $0.09 PALO ALTO, Calif., October 21, 2009 - VMware, Inc. (NYSE: VMW), the global leader in virtualization solutions from the desktop through the datacenter to the cloud, today for ...

Zurich, 26 June 2008. The rights to key patents for an innovative screening tool for treatments for cystic fibrosis were transferred today to Swiss biotech company Axentis Pharma AG. The company has acquired the rights from an Austrian firm that has made a vital contribution to the development of new approaches to treating the disease. The core element of the platform technology involves - ...